2,8-Diaza-spiro[4.5]decane-2-carboxylic Acid tert-Butyl Ester - CAS 336191-17-4
Catalog: |
BB062783 |
Product Name: |
2,8-Diaza-spiro[4.5]decane-2-carboxylic Acid tert-Butyl Ester |
CAS: |
336191-17-4 |
Synonyms: |
tert-butyl 2,8-diazaspiro[4.5]decane-2-carboxylate; 2-Boc-2,8-diazaspiro[4.5]decane; 2,8-Diaza-spiro[4.5]decane-2-carboxylic acid tert-butyl ester; 2-Boc-2,8-diaza-spiro[4.5]decane; 2,8-Diazaspiro[4.5]decane-2-carboxylic acid tert-butyl ester; 2,8-DIAZASPIRO[4.5]DECANE-2-CARBOXYLIC ACID, 1,1-DIMETHYLETHYL ESTER |
IUPAC Name: | tert-butyl 2,8-diazaspiro[4.5]decane-2-carboxylate |
Description: | 2,8-Diaza-spiro[4.5]decane-2-carboxylic Acid tert-Butyl Ester |
Molecular Weight: | 240.34 |
Molecular Formula: | C13H24N2O2 |
Canonical SMILES: | CC(C)(C)OC(=O)N1CCC2(C1)CCNCC2 |
InChI: | InChI=1S/C13H24N2O2/c1-12(2,3)17-11(16)15-9-6-13(10-15)4-7-14-8-5-13/h14H,4-10H2,1-3H3 |
InChI Key: | NFNCPNAVNRBDOU-UHFFFAOYSA-N |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-113135921-A | Dihydropyrimidine-spiro derivative and preparation method and application thereof | 20210426 |
WO-2021225969-A1 | Imino sulfanone inhibitors of enpp1 | 20200504 |
CN-112939967-A | Pyrazolo [1,5-a ] pyridine compound and preparation method and application thereof | 20191211 |
WO-2021105116-A1 | Substituted aminoquinolones as dgkalpha inhibitors for immune activation | 20191128 |
WO-2021018118-A1 | Compounds and methods for the targeted degradation of interleukin-1 receptor-associated kinase 1 proteins | 20190729 |
CN-109810108-A | 2,8- diaza-spiro-[4,5]-decane class pyrimidine-hydroxamic acid compound and application thereof | 20190320 |
CN-109810108-B | 2, 8-diaza-spiro- [4,5] -decane pyrimidine-hydroxamic acid compound and application thereof | 20190320 |
WO-2020167518-A1 | Bifunctional compounds for degrading btk via ubiquitin proteosome pathway | 20190213 |
WO-2020159285-A1 | Imidazopyridine derivative compounds and use of same | 20190201 |
KR-20200096157-A | Imidazopyridine derivative compound and use thereof | 20190201 |
Complexity: | 290 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 240.183778013 |
Formal Charge: | 0 |
Heavy Atom Count: | 17 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 240.183778013 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 41.6Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.4 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
-
[147396-07-4]
(E)-1-(Benzo[b] thiophen- 2- yl)ethanone Oxime
-
[951987-97-6]
N-((4-Oxo-1-phenyl-4,7-dihydro-1H-pyrazolo[3,4-d]pyrimidin-6-yl)methyl)acetamide
-
[548777-18-0]
1-(Pent-4-yn-1-yl)-2,5-dihydro-1H-pyrrole-2,5-dione
-
(3R,4R)-tert-Butyl 3-((6,7-Dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidine-1-carboxylate
-
(3R,4R,5S)-Methyl 5-Acetoxy-4-((methylsulfonyl)oxy)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate
-
(3R,4R,5S)-Methyl 5-Acetoxy-4-hydroxy-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS